The gloves come off for a Sunday session at the 2026 World Conference on Lung Cancer (WCLC). The session, titled The Faculty Feud: ADC Experts Live Showdown!, will be chaired by Hidehito Horinouchi, MD, PhD, and Annapaola Mariniello, MD, PhD.
In a recent interview with ILCN, Dr. Horinouchi, a thoracic medical oncologist and Director of the Center for Education and Professional Career Development at the National Cancer Center Hospital in Tokyo, Japan, previewed this upcoming interactive session and highlighted what attendees can expect.
The Faculty Feud: ADC Experts Live Showdown!
Sunday, September 13, at 16:45 Korea Standard Time (KST)
ADC experts go head-to-head in a dynamic showdown during this interactive session at WCLC 2026 in Seoul, Republic of Korea. LEARN MORE
ILCN: Can you please provide an overview of what attendees can expect at the session and explain what makes this format unique compared with traditional educational sessions and workshops?
Dr. Horinouchi: This session focuses on antibody-drug conjugates (ADCs)—currently one of the most prominent therapeutic modalities—offering lectures on the latest insights alongside interactive discussions on critical clinical challenges.
Equal time is allocated for discussion as for the lectures, and attendees will be strongly encouraged to actively participate in the discourse using interactive tools.
ILCN: How will this session address both the current and future roles of ADCs in lung cancer care?
Dr. Horinouchi: As the development of ADCs advances, the field has transitioned from simply asking “Is it an ADC?” to asking “What defines a better ADC?”
In this session, we will explore what “better” truly means through the lenses of efficacy, adverse events, and biomarkers, featuring an interactive discussion that actively incorporates insights from all participants.
ILCN: What is the main takeaway you hope that attendees walk away with from this session?
Dr. Horinouchi: Beyond simply sharing knowledge from the speakers, our goal is to leverage this interactive format to collaborate with an engaged audience, fostering meaningful discussions on the critical challenges surrounding ADCs.
ILCN: As the session chair, what are you personally looking forward to most about this event?
Dr. Horinouchi: As reflected in the title, above all, our goal is to deliver a session that is genuinely enjoyable and fun to participate in. Through our interactive tools, your active engagement holds the key to making this session a true success!
Please refer to the 2026 WCLC Scientific Program for the most up-to-date schedule information.
